Shasun Pharmaceuticals shares were locked at an upper circuit limit of 20% on Monday after the company informed the BSE that the board of directors will meet on Wednesday to consider issue of convertible warrants or preferential shares.

The scrip touched its 52-week high of Rs 105.3 before the trading on the counter was halted.